3. Materials and Methods
1H and
13C DEPTQ NMR spectra and 2D NMR experiments were recorded in solutions of DMSO-d
6 on a Bruker AVANCE-III HD (Bruker BioSpin AG, Fällanden, Switzerland) and Agilent 400/MR (Agilent Technologies, US) instruments (at 400 MHz for
1H and 101 MHz for
13C nuclei). Residual solvent signals were used as internal standards, in DMSO-d
6 (2.49 ppm for
1H, and 39.50 ppm for
13C nuclei). Single crystal X-ray diffraction analysis of compound
3d was performed on an automatic four-circle diffractometer Agilent Super Nova, Dual, Cu at zero, Atlas S2. High-resolution mass spectra (HRMS) were registered with a Bruker MaXis Impact (Bruker Daltonics, Bremen, Germany) spectrometer (electrospray ionization, using HCO
2Na–HCO
2H for calibration). The samples were dissolved in MeCN under moderate heating (37-38 °C) and ultrasonication. See
Electronic Supplementary Material file for NMR, FTIR, HRMS spectral charts and X-ray analysis data.
FT-IR spectra were measured on a Bruker Vertex 70 instrument (Bruker Optics GmbH & Co. KG, Ettlingen, Germany) equipped with an ATR sampling module. Elemental analyses were carried out using a Carlo Erba 1106 Elemental Analyzer (Carlo Erba Strumentazione, Cornaredo, Italy). Reaction progress and purity of isolated compounds were controlled by TLC on Sorbfil-A plates (Imid Ltd., Krasnodar, Russia), eluent—acetone:hexane 2:1 or ethyl acetate. Developed TLC plates were stained with UV-light and iodine vapors.
N,N′-Diphenyldithiomalondiamide (dithiomalondianilide)
1 was prepared from acetylacetone and phenyl isothiocyanate as reported [
33,
34]. (
E)-3-Aryl-2-cyanoacrylamides
2a-f were prepared by reaction of 2-cyanoacetamide with aromatic aldehydes in the presence of catalytic amounts of morpholine in EtOH at 40-50 °С [
89] or in water in the presence of surfactants [
90]. All other reagents and solvents were purchased from commercial vendors (BioInLabs, Rostov-on-Don, Russia) and used as received.
General procedure for the preparation of 6-amino-4-aryl-7-phenyl-3-(phenyl- imino)-4,7-dihydro-3H-[1,2]dithiolo[3,4-b]pyridine-5-carboxamides 3a-f (Method A). A vial was charged, under air, with dithiomalondianilide 1 (500 mg, 1.75 mmol), 3-aryl-2-cyanoacrylamide 2a-f (1.75 mmol) and EtOH (15 mL). A mixture was treated with morpholine (0.23 mL, 1.75 mmol) at 40-50 °C (internal temperature) under vigorous stirring. Complete dissolution of starting materials and formation of a deep-yellow solution occurred for a very short time (a matter of minutes). Usually, a yellow precipitate begins to separate within half an hour. The reaction mixture was stirred for another 2-3 h (TLC control) and left to stand at room temperature until crystallization was complete. The precipitated product was filtered off, washed with EtOH and purified either by flash chromatography (silica gel, eluent–acetone) or by recrystallization from acetone or acetone–EtOH mixtures to give pure dithiolopyridines 3a-f as yellow crystalline solids.
General procedure for the preparation of 6-amino-4-aryl-7-phenyl-3-(phenyl- imino)-4,7-dihydro-3H-[1,2]dithiolo[3,4-b]pyridine-5-carboxamides 3a-f (Method B). Morpholine (0.23 mL, 1.75 mmol) was added to a mixture of 2-cyanoacetamide (150 mg, 1.75 mmol) and substituted benzaldehyde (1.75 mmol) in EtOH (6-8 mL). The reaction mixture was stirred at ~60 °C for 5 min, then dithiomalondianilide 1 (500 mg, 1.75 mmol) and EtOH (10 mL) were added. The resulted mixture was stirred at 40-50 °C for 2-3 h and monitored by TLC until the starting reagents were consumed. After the reaction was complete, the reaction mixture was left to stand at room temperature for complete crystallization. The precipitated product was filtered off, washed with EtOH and purified as described above to give pure dithiolopyridines 3a-f as yellow crystalline solids.
6-Amino-4-(2-nitrophenyl)-7-phenyl-3-(phenylimino)-4,7-dihydro-3H-[1,2]dithiolo[3,4-b]-pyridine-5-carboxamide (3a). The yield was 54% (method A) or 43% (method B). 1H NMR (400 MHz, DMSO-d6): 5.64 (s, 1H, H-4), 6.63 (br s, 2H, NH2), 6.73 (d, 3J = 7.5 Hz, 2H, H-2 H-6 Ph), 7.03-7.07 (m, 1H, H-4 Ph), 7.28-7.32 (m, 2H, H-3 H-5 Ph), 7.44-7.49 (m, 1H, H-4 Ar), 7.58 (br s, CONH2), 7.64-7.69 (m, 5H, Ph), 7.78-7.83 (m, 3H, Ar). 13C NMR (101 MHz, DMSO-d6): 34.6 (C-4), 77.6 (C-5), 111.1 (C-3a), 120.0 (2C, C-2 C-6 Ph), 123.4 (C-3 Ar), 124.2 (C-4 Ph), 127.9 (C-4 Ar), 129.4 (2C, C-3 C-5 Ph), 130.2 (CH Ph), 130.4 (CH Ph), 131.0 (C-6 Ar), 134.2 (C-5 Ar), 135.5 (C-1 Ph), 140.0 (C-1 Ar), 148.5 (C-NO2), 150.5 (C-1 Ph), 152.0 (C-6), 154.4 (C-7a), 163.3 (C-3), 171.1 (CONH2). FTIR, νmax, cm-1: 3439, 3350, 3171, 3119, 3063 (N-H, C-H); 1668 (C=O); 1645 (C=N); 1533 (NO2 asym); 1357 (NO2 sym). HRMS (ESI) m/z: calculated for C25H20N5O3S2 [M+H]+: 502.1008, found 502.1023 (Δ 2.99 ppm).
6-Amino-4-(4-chlorophenyl)-7-phenyl-3-(phenylimino)-4,7-dihydro-3H-[1,2]dithiolo[3,4-b]pyridine-5-carboxamide (3b). The yield was 40% (method A) or 33% (method B). 1H NMR (400 MHz, DMSO-d6): 5.24 (s, 1H, H-4), 6.55 (br s, 2H, NH2), 6.84 (d, 3J = 7.5 Hz, 2H, H-2 H-6 Ph), 7.07-7.10 (m, 1H, H-4 Ph), 7.30-7.39 (m, 6H, H-3 H-5 Ph, 2H Ar, CONH2 overlapped), 7.43 (d, 3J = 8.3 Hz, 2H, H Ar), 7.60–7.67 (m, 5H, Ph). 13C NMR (101 MHz, DMSO-d6): 38.6 (C-4), 78.0 (C-5), 112.4 (C-3a), 120.0 (2C, C-2 C-6 Ph), 124.2 (C-4 Ph), 127.8 (2C, CH Ar), 129.5 (2C, CH Ar), 129.7 (2C, C-3 C-5 Ph), 130.1 (CH Ph), 130.5 (CH Ph), 131.0 (CH Ph), 135.4 (C–Cl), 135.6 (C-1 Ph), 146.6 (C-1 Ar), 150.8 (C-1 Ph), 152.0 (C-6), 154.5 (C-7a), 163.1 (C-3), 171.3 (CONH2). FTIR, νmax, cm-1: 3406, 3300, 3151, 3055 (N-H, C-H); 1662 (C=O, C=N). HRMS (ESI) m/z: calculated for C25H20ClN4OS2 [M+H]+: 491.0767, found 491.0780 (Δ 2.65 ppm).
6-Amino-4-(3-nitrophenyl)-7-phenyl-3-(phenylimino)-4,7-dihydro-3H-[1,2]dithiolo[3,4-b]pyridine-5-carboxamide (3c). The yield was 37% (method A) or 27% (method B). 1H NMR (400 MHz, DMSO-d6): 5.32 (s, 1H, H-4), 6.58 (br s, 2H, NH2), 6.89 (d, 3J = 7.5 Hz, 2H, H-2 H-6 Ph), 7.06-7.10 (m, 1H, H-4 Ph), 7.32-7.36 (m, 2H, H-3 H-5 Ph), 7.40 (br s, CONH2), 7.58-7.67 (m, 6H, H-5 Ar + Ph), 8.01 (br d, 3J = 7.5 Hz, H-6 Ar), 8.08 (dd, 3J = 8.2 Hz, 3J = 1.4 Hz, H-4 Ar), 8.58-8.59 (m, 1H, H-2 Ar). 13C NMR (101 MHz, DMSO-d6): 38.7 (C-4), 78.7 (C-5), 111.2 (C-3a), 120.0 (2C, C-2 C-6 Ph), 121.3 (С-4 Ar), 122.6 (C-2 Ar), 124.3 (C-4 Ph), 129.4 (С-5 Ar), 129.7 (2C, C-3 C-5 Ph), 130.0 (CH Ph), 130.4 (CH Ph), 130.9 (CH Ph), 134.1 (C-6 Ar), 135.7 (C-1 Ph), 147.3 (С-1 Ar), 148.0 (C-NO2), 150.9 (C-1 Ph), 151.4 (C-6), 154.7 (C-7a), 163.2 (C-3), 171.2 (CONH2). FTIR, νmax, cm-1: 3493, 3458, 3444, 3402, 3342, 3211, 3057 (N-H, C-H); 1647 (C=O, C=N), 1575 (NO2 asym); 1348 (NO2 sym). HRMS (ESI) m/z: calculated for C25H20N5O3S2 [M+H]+: 502.1008, found 502.1023 (Δ 2.99 ppm).
6-Amino-4-(2,4-dichlorophenyl)-7-phenyl-3-(phenylimino)-4,7-dihydro-3H-[1,2]dithiolo[3,4-b]pyridine-5-carboxamide (3d). The yield was 39% (method A) or 31% (method B). According to NMR, after recrystallization from acetone–EtOH mixture the product appeared as solvate 3d:EtOH = 2:1. 1H NMR (400 MHz, DMSO-d6): 1.05 (t, 3J = 6.8 Hz, 3H, EtOH), 3.43-3.46 (m, 2H, EtOH), 4.33 (t, 3J = 5.0 Hz, 1H, EtOH), 5.31 (s, 1H, H-4), 6.26 (br s, 2H, NH2), 6.79 (d, 3J = 7.5 Hz, 2H, H-2 H-6 Ph), 7.02-7.06 (m, 1H, H-4 Ph), 7.28-7.31 (m, 4H, H-3 H-5 Ph, CONH2), 7.39 (dd, 3J = 8.2 Hz, 4J = 1.7 Hz, H-5 Ar), 7.48 (d, 4J = 1.7 Hz, H-3 Ar), 7.60-7.64 (m, 5H, Ph), 7.73 (d, 3J = 8.2 Hz, H-6 Ar). 13C NMR (101 MHz, DMSO-d6): 18.5 (CH3 EtOH), 38.7 (C-4), 56.0 (CH2 EtOH), 77.9 (C-5), 109.8 (C-3a), 120.0 (2C, C-2 C-6 Ph), 124.1 (C-4 Ph), 126.9 (C-5 Ar), 128.6 (C-3 Ar), 129.5 (2C, C-3 C-5 Ph), 130.29 (CH Ph), 130.32 (CH Ph), 130.9 (CH Ph), 131.4 (C-4 Ar), 133.0 (C–Cl Ar), 133.9 (C-6 Ar), 135.6 (C-1 Ph), 141.4 (C-1 Ar), 150.3 (C-1 Ph), 151.0 (C-6), 154.9 (C-7a), 162.1 (C-3), 171.3 (CONH2). FTIR, νmax, cm-1: 3473, 3363, 3333, 3144, 3051 (N-H, C-H); 1707 (C=O), 1633 (C=N). HRMS (ESI) m/z: calculated for C25H18Cl2N4NaOS2 [M+Na]+: 547.0197, found 547.0174 (Δ 4.2 ppm).
6-Amino-4-(3,4-dimethoxyphenyl)-7-phenyl-3-(phenylimino)-4,7-dihydro-3H-[1,2]dithiolo[3,4-b]pyridine-5-carboxamide (3e). The yield was 40% (method A) or 22% (method B). 1H NMR (400 MHz, DMSO-d6): 3.79 (s, 3Н, MeO–Ar), 3.84 (s, 3Н, MeO–Ar), 5.00 (s, 1H, H-4), 6.30 (br s, 2H, NH2), 6.82–6.90 (m, 5H, H Ph, H Ar), 7.06-7.10 (m, 1H, H-4 Ph), 7.28-7.33 (m, 4H, H-3 H-5 Ph, CONH2), 7.55–7.66 (m, 5H, H Ar).13C NMR (101 MHz, DMSO-d6): 38.0 (C-4), 54.9 (ArOCH3), 55.0 (ArOCH3), 79.1 (C-5), 110.8 (C-3a), 111.2 (CH Ar), 112.0 (CH Ar), 118.9 (CH Ar), 120.1 (2C, C-2 C-6 Ph), 124.3 (C-4 Ph), 129.6 (2C, C-3 C-5 Ph), 129.9 (2C, CH Ph), 130.4 (2C, CH Ph), 130.9 (C-4 Ph), 135.5 (C-1 Ph), 137.2 (C-1 Ar), 147.7 (C–OMe), 148.3 (C–OMe), 150.4 (C-1 Ph), 151.5 (C-6), 154.0 (C-8a), 163.0 (C=N), 171.1 (C=O). FTIR, νmax, cm-1: 3475, 3388, 3267, 3178, 3047 (N-H, C-H); 1668 (C=O), 1633 (C=N). Elemental Analysis (С27Н24N4O3S2, M 516,63): calculated (%): C, 62.77; H, 4.68; N, 10.84; found (%): C, 62.57; H, 4.90; N, 10.79.
6-Amino-4-(4-methoxyphenyl)-7-phenyl-3-(phenylimino)-4,7-dihydro-3H-[1,2]dithiolo[3,4-b]pyridine-5-carboxamide (3f). The yield was 54% (method A) or 35% (method B). 1H NMR (400 MHz, DMSO-d6): 3.74 (s, 3Н, MeO–Ar), 4.94 (s, 1H, H-4), 6.26 (br s, 2H, NH2), 6.81 (d, 3J = 7.5 Hz, 2H, H-2 H-6 Ph), 6.93 (d, 3J = 8.4 Hz, 2H, H-Ar), 7.04-7.08 (m, 1H, H-4 Ph), 7.29-7.37 (m, 6H, H-3 H-5 Ph, H Ar, CONH2), 7.55–7.63 (m, 5H, H Ar). 13C DEPTQ NMR (101 MHz, DMSO-d6): 37.9 (C-4), 54.9 (OCH3), 78.0 (C-5), 113.0 (C-3a), 113.5 (2C, CH Ar), 120.1 (2C, C-2 C-6 Ph), 124.3 (C-4 Ph), 128.0 (2C, CH Ar), 129.5 (2C, C-3 C-5 Ph), 130.0 (2C, CH Ph), 130.3 (2C, CH Ph), 131.0 (C-4 Ph), 135.5 (C-1 Ph), 138.9 (C-1 Ar), 150.7 (C-1 Ph), 152.0 (C-6), 153.9 (C-8a), 157.5 (C–OMe), 163.1 (C=N), 171.1 (C=O). HRMS (ESI) m/z: calculated for C26H22N4O2S2 [M+H]+: 487.1262, found 487.1276 (Δ 2.87 ppm).
X-ray studies for single crystals of 3d.
Single crystals of 6-amino-4-(2,4-dichlorophenyl)-7-phenyl-3-(phenylimino)- 4,7-dihydro-3H-[1,2]dithiolo[3,4-b]pyridine-5-carboxamide
3d (C
25H
18Cl
2N
4OS
2, M 525.45 g/mol) were prepared by slow evaporation of saturated solution in DMSO. The crystal was kept at 100.01(10) K during data collection. Using Olex2 [
91], the structure was solved with the olex2.solve structure solution program using Charge Flipping and refined with the SHELXL [
92] package using Gauss-Newton minimisation.
The crystals are monoclinic, space group I2/a (no. 15), at 100.01(11) K: a = 11.97350(10) Å, b = 12.96920(10) Å, c = 34.4739(2) Å, α = 90°, β = 90.7890(10)°, γ = 90°, V = 5352.83(7) Å3, Z = 8, μ(Cu Kα) = 3.837 mm-1, Dcalc = 1.304 g/cm3, F(000) = 2160.0, 29542 reflections measured (7.282° ≤ 2Θ ≤ 153.23°), 5572 unique (Rint = 0.0263, Rsigma = 0.0158) which were used in all calculations. The final R1 was 0.0352 (I > 2σ(I)) and wR2 was 0.0939 (all data).
A full set of crystallographic data has been deposited in the Cambridge Crystallographic Data Center (CCDC 2310349).
Herbicide safening effect studies.
Germinated sunflower seeds (cv. Master) with 2-4 mm long embryo roots were placed in a solution of 2,4-D (10
–3% by weight) for 1 h to achieve 40‒60% inhibition of hypocotyls growth. After treatment the seedlings were washed with pure water and placed into a solution of the corresponding compound
3b,
3d and
3f (concentrations 10
–2, 10
–3, 10
–4 or 10
–5% by weight, “herbicide + antidote” experiments). After 1 h the seedlings were washed with pure water and placed on paper stripes (10×75 cm, 20 seeds per stripe). The stripes were rolled and placed into beakers with water (50 cm
3). The reference group of seedlings (“herbicide” experiments) was kept in 2,4-D solution (10
–3%) for 1 h and then in water for 1 h. The “control” seedlings were kept in water for 2 h. The temperature of all solutions was maintained at 28 °C. The seedlings were then thermostated for 3 days at 28 °С. Each experiment was performed in triplicate, 20 seeds were used in each experiment. The results are given in
Table 2.